公开(公告)号：US10436785B2

公开(公告)日：2019-10-08

申请号：US15363832

申请日：2016-11-29

Applicant: Spring BioScience Corporation

Inventor： Fernando Jose Rebelo do Couto ,  Zhiming Liao ,  Yifei Zhu

IPC: G01N33/573 ,  C07K16/40 ,  C12N9/02 ,  C12N9/96 ,  G01N33/574

Abstract: The invention provides antibodies that bind specifically to human indoleamine 2,3-dioxygenase 1 (IDO1), and methods of using the same. The antibodies are capable of binding to a sequence comprising SEQ ID NO: 1 and specifically bind to human IDO1 in formalin fixed paraffin embedded tissues. The antibodies are useful in a number of different analytical techniques, including immunohistochemistry (IHC) and immunocytochemistry (ICC).

公开(公告)号：US20150346208A1

公开(公告)日：2015-12-03

申请号：US14725953

申请日：2015-05-29

Applicant: SPRING BIOSCIENCE CORPORATION

Inventor： Fernando Jose Rebelo do Couto ,  Zhiming Liao ,  Yifei Zhu

IPC: G01N33/574 ,  C07K16/28

CPC classification number: G01N33/57492 ,  C07K16/2827 ,  C07K16/2896 ,  C07K2317/34 ,  C07K2317/51 ,  C07K2317/515 ,  C07K2317/92 ,  G01N2333/70596

Abstract: Provided herein are novel PD-L1 antibodies and methods for using the same for diagnosing a medical condition associated with elevated PD-L1 levels (e.g., cancer) in subjects in need thereof and antigen binding fragments thereof. The PD-L1 antibodies and antigen binding fragments are also useful in evaluating the efficacy of a particular therapeutic regime in a subject diagnosed as having a PD-L1-related medical condition.

Abstract translation: 本文提供了新的PD-L1抗体及其用于诊断与有需要的受试者中的升高的PD-L1水平（例如癌症）和其抗原结合片段相关的医学病症的方法。 PD-L1抗体和抗原结合片段也可用于评估诊断为患有PD-L1相关医学病症的受试者中特定治疗方案的功效。